Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

NIH Ends Gene Therapy Trial Reporting Requirements In Reg Streamlining Move

Aug 16 2018

• By Derrick Gingery

Gene editiing

Related Content

Spark's Early Christmas Present: US FDA Approves Luxturna For Vision Loss

Dec 19 2017

CBER Implements Pre-Clinical Meeting Program For Biologics, Gene Therapy Sponsors

Jun 22 2018

Gene Therapy 'Cassettes' Could Speed, Cheapen Manufacturing, Gottlieb Says

May 24 2018

Gene Therapy Oversight To Be Streamlined By US FDA, NIH

Aug 02 2018

Related Companies

Spark Therapeutics, Inc.

uniQure N.V.

Additional Topics

United States Regenerative Medicine Regulation Biologics FDA BioPharmaceutical

More from Cell & Gene Therapies

More from Advanced Technologies

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window